RSC Publishing


Publishing

 

Cover image for Highlights in Chemical Biology

Highlights in Chemical Biology

Chemical biology news from across RSC Publishing.



Protein activity tied in knots


12 March 2008

UK scientists have engineered a molecular knot that inhibits an enzyme crucial to foot-and-mouth disease, an infectious disease amongst cloven-hoofed animals. 

Edward Tate, Robin Leatherbarrow and colleagues from Imperial College London have looked to natural product cyclotides to create analogues that inhibit a range of protein-digesting enzymes. Among these was the first reported peptidic inhibitor of the enzyme FMDV 3Cpro - essential for the foot-and-mouth disease virus (FMDV) to replicate.

"By re-engineering the cyclotides, their inhibitory activity can be redirected towards an alternative protease target"
'Cyclotides are small proteins of around 30 amino acids that contain both a head-to-tail macrolactam backbone and a cystine knot, an arrangement of three disulfide bonds between pairs of cysteine residues, whereby two bonds form a loop through which the third is threaded,' said Tate. After carrying out the total synthesis of cyclotides from the MCoTI family, the UK team re-engineered the rigid and well-defined structures to create analogues with different biological activities.

MCoTI cyclotides are potent inhibitors of trypsin, a protease enzyme that breaks down proteins in the digestive system. By re-engineering the proteins, the cyclotides' inhibitory activity can be redirected towards an alternative protease target, Tate explained. This included a protease from a completely different mechanistic class: a cysteine protease from foot and mouth disease virus.

A cyclotide showing three disulfide bonds

Cyclotides contain three disulfide bonds (yellow) and form a cystine knot

Whilst it is not the first FMDV protease inhibitor reported, Tate explained, 'to my knowledge, it is the most effective reported inhibitor in a controlled assay against the enzyme in isolation.' He added that, although the cyclotides were too complex for use as an animal drug, his results could help guide future non-cyclotide based inhibitor design for the FMDV enzyme. 

'The more interesting thing is that the analogues can inhibit a cysteine protein at all, since this is a very different class of protease from that typically targeted by MCoTI cylotides,' said Tate. 'The ease with which these structurally complex cyclotides can now be synthesised and re-engineered will enable new studies into their biological activity, for example, as potential peptide-based drugs.'

David Craik, from the University of Queensland in Brisbane, Australia, who studies protein structures relevant to drug design, agreed: 'The work represents an exciting development in the field of cystine knot proteins. By demonstrating a high yielding chemo-enzymatic approach to their synthesis as well as the ability to engineer tailored enzyme inhibitory activity into them, it is likely to greatly enhance applications of this ultra-stable class of proteins as drug development scaffolds.'

Elinor Richards

Link to journal article

Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides
Panumart Thongyoo, Núria Roqué-Rosell, Robin J. Leatherbarrow and Edward W. Tate, Org. Biomol. Chem., 2008, 6, 1462
DOI: 10.1039/b801667d

Also of interest

Spider

Instant insight: Venomous drugs?

15 December 2006

Setting the record straight about spiders...